Blood News and Research

RSS

New research enables ‘tailored’ diet advice based on personal gut microbiome

New research enables "tailored" diet advice - based on our personal gut microbiome - for persons who want to lose weight and reduce the risk of disease.

10 Sep 2015

Researchers use nanopore technology for early detection of colorectal and lung cancers

Using tiny "nanopore" scanners that can detect individual DNA molecules, Professor Amit Meller and colleagues are on the hunt for biological markers in cancer cells that may help clinicians diagnose colorectal and lung cancers at their earliest stages.

10 Sep 2015

New digital emergency services tool launched for military families

The American Red Cross is launching a new digital tool that gives military families the option to quickly communicate an emergency message from a computer, tablet or smartphone at redcross.org/HeroCareNetwork.

10 Sep 2015

New trial results show efficacy of novel enzyme-replacement therapy for genetic lipid disorder

Of the more than 50 known lysosomal storage diseases (LSDs)-rare inherited metabolic disorders-only seven can be treated with approved enzyme-replacement therapies.

10 Sep 2015

Researchers discover potential biomarker for episodic migraine

Researchers may have discovered a new marker found in the blood for episodic migraine, according to a study published in the September 9, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

10 Sep 2015

Deadly parasite that causes Chagas disease widespread in Texas bugs

A deadly parasite that causes Chagas disease is widespread in a common Texas insect, according to a new study by University of Texas at El Paso researchers. The finding suggests that the risk of Texans contracting the disease may be higher than previously thought.

10 Sep 2015

Scientists develop a way to stop pharmaceuticals from contaminating drinking water

In recent years, researchers have realized that many products, including pharmaceuticals, have ended up where they're not supposed to be -- in our drinking water. But now scientists have developed a way to make drugs that break down into harmless compounds before they contaminate our taps.

10 Sep 2015

Liver failure patients may benefit from CSF-1 treatment that aids the immune system to combat infections

Patients with liver failure could benefit from a treatment that helps the immune system to combat infections linked to the condition, research suggests.

10 Sep 2015

Simple stem cell production method shows promise in mice for treating IPF

In a small pilot study, researchers from North Carolina State University have demonstrated a rapid, simple way to generate large numbers of lung stem cells for use in disease treatment. This method of harvesting and growing a patient's own lung stem cells shows promise in mice for treating idiopathic pulmonary fibrosis (IPF), and could one day provide human IPF sufferers with an effective, less invasive method of treatment for their disease.

10 Sep 2015

Riddell, TGen start third year of study to advance concussion treatment with ASU's football program

Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.

10 Sep 2015

Research opens up potential new pathways to vaccine development against HA-MRSA

New research led by NYU Langone Medical Center has uncovered why a particular strain of Staphylococcus aureus -- known as HA-MRSA -- becomes more deadly than other variations. These new findings open up possible new pathways to vaccine development against this bacterium, which the Centers for Disease Control and Preventions says accounts for over 10,000 deaths annually, mostly among hospital patients.

10 Sep 2015

HUCBC-derived monocytes diminishes Aβ pathology, improves cognition in AD modeled mice

Alzheimer's disease (AD), which affects an estimated 26 million people worldwide, is the fourth leading cause of death among the elderly and the leading cause of dementia. Predictions are that the number of AD cases will quadruple by 2050.

9 Sep 2015

New $2.8 million NIH grant to help researchers find better treatments for hemorrhagic strokes

Developing better treatments and an improved understanding of the biology behind brain injury from hemorrhagic strokes is the main goal of a three-year $2.8 million grant to the Translational Genomics Research Institute, Phoenix Children's Hospital, and Barrow Neurological Institute.

9 Sep 2015

Latest ENT research to be presented at AAO-HNSF's annual meeting

The latest research on hearing loss, head and neck cancers, sleep apnea and other otolaryngic topics will be presented in Dallas, TX, September 27-30, at the 2015 Annual Meeting & OTO EXPO? of the American Academy of Otolaryngology--Head and Neck Surgery Foundation (AAO-HNSF), the largest annual meeting of ear, nose, throat, head and neck physicians in the world.

9 Sep 2015

Regular physical trauma may put professional football players at increased risk for hypertension

The regular physical trauma that appears to put professional football players at risk for degenerative brain disease may also increase their risk for hypertension and cardiovascular disease, researchers say.

9 Sep 2015

New programme to prevent development of Type 2 diabetes achieves promising early results

A programme aimed at preventing the development of Type 2 diabetes in people at high risk of the disease has achieved "promising" early results, a study has found.

9 Sep 2015

AcelRx's ARX-04 meets primary and secondary endpoints in Phase 3 trial

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that ARX-04 (sufentanil sublingual tablet, 30 mcg) met primary and secondary endpoints in a multi-center, double-blind, placebo-controlled Phase 3 trial (SAP301) designed to study the short-term treatment of patients with moderate-to-severe acute pain following ambulatory abdominal surgery.

9 Sep 2015

Dietary uptake of microRNAs certainly insufficient to affect physiological functions, reveal ETH biologists

The scientific world was astonished when, in 2011, Chinese researchers claimed to have found evidence suggesting that minute fragments of plant genetic material - so-called microRNA molecules - of rice ingested from food could play a role in regulating physiological processes in the human body. If this is indeed true, it might even be possible to deliberately modify human physiological functions via this route, for instance by incorporating microRNAs into novel functional foods.

9 Sep 2015

Egalet announces launch of OXAYDO (oxycodone HCI, USP) Tablets and IMPACT-Rx initiative

Egalet Corporation, a fully integrated specialty pharmaceutical company focused on discovering, developing and commercializing innovative pain treatments, today announced the launch of OXAYDO (oxycodone HCI, USP) tablets -CII in the United States.

9 Sep 2015

Simple test can lead to early detection of sleep apnea in hospitalized heart failure patients

Researchers at Thomas Jefferson University showed that a simple questionnaire, evaluation and pulse-oximetry monitoring can lead to early detection of sleep apnea in patients hospitalized for congestive heart failure (CHF).

9 Sep 2015

Blood News and Research

New research enables ‘tailored’ diet advice based on personal gut microbiome

Researchers use nanopore technology for early detection of colorectal and lung cancers

New digital emergency services tool launched for military families

New trial results show efficacy of novel enzyme-replacement therapy for genetic lipid disorder

Researchers discover potential biomarker for episodic migraine

Deadly parasite that causes Chagas disease widespread in Texas bugs

Scientists develop a way to stop pharmaceuticals from contaminating drinking water

Liver failure patients may benefit from CSF-1 treatment that aids the immune system to combat infections

Simple stem cell production method shows promise in mice for treating IPF

Riddell, TGen start third year of study to advance concussion treatment with ASU's football program

Research opens up potential new pathways to vaccine development against HA-MRSA

HUCBC-derived monocytes diminishes Aβ pathology, improves cognition in AD modeled mice

New $2.8 million NIH grant to help researchers find better treatments for hemorrhagic strokes

Latest ENT research to be presented at AAO-HNSF's annual meeting

Regular physical trauma may put professional football players at increased risk for hypertension

New programme to prevent development of Type 2 diabetes achieves promising early results

AcelRx's ARX-04 meets primary and secondary endpoints in Phase 3 trial

Dietary uptake of microRNAs certainly insufficient to affect physiological functions, reveal ETH biologists

Egalet announces launch of OXAYDO (oxycodone HCI, USP) Tablets and IMPACT-Rx initiative

Simple test can lead to early detection of sleep apnea in hospitalized heart failure patients

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News